Literature DB >> 20506259

Temporal and spatial expression of osteoactivin during fracture repair.

Samir M Abdelmagid1, Mary F Barbe, Michael Hadjiargyrou, Thomas A Owen, Roshanak Razmpour, Saqib Rehman, Steven N Popoff, Fayez F Safadi.   

Abstract

We previously identified osteoactivin (OA) as a novel secreted osteogenic factor with high expression in developing long bones and calvaria, and that stimulates osteoblast differentiation and matrix mineralization in vitro. In this study, we report on OA mRNA and protein expression in intact long bone and growth plate, and in fracture calluses collected at several time points up to 21 days post-fracture (PF). OA mRNA and protein were highly expressed in osteoblasts localized in the metaphysis of intact tibia, and in hypertrophic chondrocytes localized in growth plate, findings assessed by in situ hybridization and immunohistochemistry, respectively. Using a rat fracture model, Northern blot analysis showed that expression of OA mRNA was significantly higher in day-3 and day-10 PF calluses than in intact rat femurs. Using in situ hybridization, we examined OA mRNA expression during fracture healing and found that OA was temporally regulated, with positive signals seen as early as day-3 PF, reaching a maximal intensity at day-10 PF, and finally declining at day-21 PF. At day-5 PF, which correlates with chondrogenesis, OA mRNA levels were significantly higher in the soft callus than in intact femurs. Similarly, we detected high OA protein immunoexpression throughout the reparative phase of the hard callus compared to intact femurs. Interestingly, the secreted OA protein was also detected within the newly made cartilage matrix and osteoid tissue. Taken together, these results suggest the possibility that OA plays an important role in bone formation and serves as a positive regulator of fracture healing.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20506259     DOI: 10.1002/jcb.22702

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

1.  Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function.

Authors:  Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Joyce Y Belcher; Bing Yu; Hilary Stinnett; Kimberly Novak; Thomas Mbimba; Matthew Khol; Kurt D Hankenson; Christopher Malcuit; Fayez F Safadi
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

2.  Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.

Authors:  Nagat Frara; Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Vanessa R Yingling; Thomas A Owen; Steven N Popoff; Mary F Barbe; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2016-01       Impact factor: 6.384

3.  Establishment of a mouse model for injury-induced scar formation and the accompanying chronic pain: Comprehensive microarray analysis of molecular expressions in fibrosis and hyperalgesia.

Authors:  Yuqiang Li; Hiroki Iida; Koji Kimata; Lisheng Zhuo; Akinobu Ota; Shinya Kimura; Xiaojian Yin; Masataka Deie; Takahiro Ushida
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

4.  Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.

Authors:  Samir M Abdelmagid; Joyce Y Belcher; Fouad M Moussa; Suzanne L Lababidi; Gregory R Sondag; Kimberly M Novak; Afif S Sanyurah; Nagat A Frara; Roshanak Razmpour; Fabiola E Del Carpio-Cano; Fayez F Safadi
Journal:  Am J Pathol       Date:  2014-01-23       Impact factor: 4.307

5.  The intracellular domain of teneurin-1 induces the activity of microphthalmia-associated transcription factor (MITF) by binding to transcriptional repressor HINT1.

Authors:  Jonas Schöler; Jacqueline Ferralli; Stéphane Thiry; Ruth Chiquet-Ehrismann
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

6.  ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties.

Authors:  April A N Rose; Matthew G Annis; Zhifeng Dong; Francois Pepin; Michael Hallett; Morag Park; Peter M Siegel
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

7.  The skeletal site-specific role of connective tissue growth factor in prenatal osteogenesis.

Authors:  Alex G Lambi; Talia L Pankratz; Christina Mundy; Maureen Gannon; Mary F Barbe; Joan T Richtsmeier; Steven N Popoff
Journal:  Dev Dyn       Date:  2012-11-05       Impact factor: 3.780

8.  Intrathecal siRNA against GPNMB attenuates nociception in a rat model of neuropathic pain.

Authors:  Lili Hou; Yanfeng Zhang; Yong Yang; Kai Xiang; Qindong Tan; Qulian Guo
Journal:  J Mol Neurosci       Date:  2014-07-17       Impact factor: 3.444

9.  Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.

Authors:  Oneida A Arosarena; Raul A Dela Cadena; Michael F Denny; Evan Bryant; Eric W Barr; Ryan Thorpe; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2016-02-08       Impact factor: 6.384

10.  Performance of repetitive tasks induces decreased grip strength and increased fibrogenic proteins in skeletal muscle: role of force and inflammation.

Authors:  Samir M Abdelmagid; Ann E Barr; Mario Rico; Mamta Amin; Judith Litvin; Steven N Popoff; Fayez F Safadi; Mary F Barbe
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.